Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis’s Afinitor Wins FDA Approval for Jobs’s Cancer Type
Bloomberg
Friday, May 6, 2011 - 8:06am
tags:
Novartis, Afinitor, FDA, pancreatic cancer
Pfizer’s Decade At A Glance
Forbes
Friday, May 6, 2011 - 8:05am
tags:
Pfizer
Sanofi-Aventis opts out of Metabolex diabetes drug deal
Bizjournals.com
Friday, May 6, 2011 - 8:01am
tags:
Metabolex, diabetes, Sanofi
Targacept profit climbs 85 percent
Bizjournals.com
Friday, May 6, 2011 - 7:47am
tags:
Targacept, earnings
Higher-than-Expected Loss at Onyx
Yahoo/Zacks.com
Thursday, May 5, 2011 - 1:58pm
tags:
ONYX Pharmaceuticals, earnings
Vanda 1Q profit falls 74 percent on revenue drop
Yahoo/AP
Thursday, May 5, 2011 - 1:57pm
tags:
earnings, Vanda
Merck, Teva Near Settlement Over Vytorin Copy, Records Show
Bloomberg
Thursday, May 5, 2011 - 1:56pm
tags:
Merck, Teva Pharmaceuticals, Vytorin, generics
Tomorrow Never Comes: Pfizer Says $1.5B in Savings Will Show Up … Next Year
BNET Pharma
Thursday, May 5, 2011 - 10:55am
tags:
Pfizer, earnings, Wyeth
Par 1Q profit falls on costs, lower sales
Yahoo/AP
Thursday, May 5, 2011 - 10:53am
tags:
Par Pharmaceutical, earnings
Glaxo May Settle 1,000 More Avandia Lawsuits, Attorney Says
Bloomberg Businessweek
Thursday, May 5, 2011 - 9:35am
tags:
settlements, GSK, Avandia, diabetes
Astra, Merck asthma pills as good as inhaler-study
Reuters
Thursday, May 5, 2011 - 9:34am
tags:
AstraZeneca, Merck, asthma, inhaler, Singulair, Accolate, leukotriene receptor antagonists, LRAs
Pharming For Business? More Docs Have An iPad
Pharmalot
Thursday, May 5, 2011 - 9:31am
tags:
iPad, physicians
Pfizer Says European Commission Approves Revatio
Bloomberg
Thursday, May 5, 2011 - 9:29am
tags:
Pfizer, Europe, Revatio, PAH
NuPathe to receive US patent for its migraine patch
Pharmabiz.com
Thursday, May 5, 2011 - 7:36am
tags:
migraines, patents, NuPathe
Novo Nordisk Sees Lower U.S. Price Increases Amid Health Reform
Bloomberg
Thursday, May 5, 2011 - 7:33am
tags:
healthcare reform, Novo Nordisk
Ranbaxy Falls Most in 6 Weeks After $1 Billion Fines Report
Bloomberg
Thursday, May 5, 2011 - 7:31am
tags:
Ranbaxy, India, Daiichi Sankyo
Evidence For Abilify & Bipolar Disorder Is Debated
Pharmalot
Wednesday, May 4, 2011 - 8:53pm
tags:
Abilify, bipolar disorder, Bristol-Myers Squibb
Cell Therapeutics: Denied but Not Rejected
Motley Fool
Wednesday, May 4, 2011 - 8:50pm
tags:
Cell Therapeutics, pixantrone, FDA
Adventrx Poised for Run-Up Before FDA Decision
Seeking Alpha
Wednesday, May 4, 2011 - 8:48pm
tags:
Adventrx, FDA, Exelbine
Ariad Pharma books bigger 1Q loss on charge
Yahoo/AP
Wednesday, May 4, 2011 - 8:46pm
tags:
Ariad Pharmaceuticals, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.